Funder: National Institutes of Health (NIH)
Due Dates: February 24, 2025 | February 23, 2026 | September 4, 2026
Funding Amounts: Up to $350,000 total costs for Phase I (up to 6 months); up to $2.15M total costs for Phase II (up to 2 years).
Summary: Supports U.S. small businesses developing automated, miniaturized tissue chip systems to advance drug development and biomedical research.
Key Information: Clinical trials are not allowed; only U.S. small businesses are eligible.